Skip to main content

Yale IVC Filter Study: Benefits Unclear

By May 13, 2016February 28th, 2018IVC Filters

inferior vena cavaIn March 2016, a medical journal published a study on IVC filters conducted by the Yale School of Medicine. The study, “Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism : Medicare Hospitalizations From 1999 to 2010”, appeared in the Journal of the American College of Cardiology.

The Yale researchers found that lots of patients—1 in 6—received an inferior vena cava (IVC) filter to prevent pulmonary embolism, a condition in which a blood clot is in the lungs. From their findings, they concluded that IVC filter benefits are still unclear, and that’s why the lead researcher called for additional studies.

The researchers felt that more patients received an IVC filter than necessary, and future research could potentially pinpoint which patients would be ideal candidates for an IVC filter implant.

IVC Filter Risks

Documented IVC filter risks include device migration, fracture, and perforation. IVC filters have been known to become dislodged, and migrate towards the heart and lungs.

These medical devices have also fractured, with fragments migrating to the heart and lungs. In addition, IVC filters have perforated the inferior vena cava (IVC) vein and other organs and tissues in some patients.

We can help.

If you or a loved one suffered an IVC filter injury from the Bard Recovery filter, Bard G2 filter, Cook Gunther Tulip filter, or another model of IVC filter, we encourage you to explore your legal options with one of our attorneys.

Carey Danis & Lowe offers free, no obligation case evaluations, in which we help you determine if filing an IVC filter lawsuit is right for you.

Call our law firm today — 1-800-721-2519. You can also reach us online through our confidential personal injury claim form.